英文名稱 |
中文名稱 |
CAS號 |
操作 |
Spiro[azetidine-3,1′(3′H)-isobenzofuran], 5′-bromo-, hydrochloride (1:1) |
沙羅拉納 |
2089316-25-4 |
詳細(xì)
|
Methyl thioglycolate |
阿替卡因 |
2365-48-2 |
詳細(xì)
|
5-BROMO-2-IODOBENZENEMETHANOL |
沙羅拉納 |
199786-58-8 |
詳細(xì)
|
synthesis-15 |
SYNTHESIS-15標(biāo)準(zhǔn)品001 |
21165-19-5 |
詳細(xì)
|
3-(2-Chloropropionyl)amino-4-methyl-2-methoxycarbonylthiophene |
阿替卡因 |
23964-56-9 |
詳細(xì)
|
SNAC |
1,6-2-HYDROXYBENZOYLAMINOHEXANE |
20073-95-4 |
詳細(xì)
|
Tadalafil Impurity 39 |
他達(dá)拉非 |
2058231-08-4 |
詳細(xì)
|
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-methoxy-, (12aR)- |
瑪巴洛沙韋 |
2136287-80-2 |
詳細(xì)
|
1,1'-Biphenyl, 4-(2-nitroethyl)- |
塞克比曲 |
182680-37-1 |
詳細(xì)
|
Benzenebutanenitrile, α-(aminomethylene)-2-fluoro-γ-oxo-, (αZ)- |
伏諾拉生 |
2304978-59-2 |
詳細(xì)
|
1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one |
氟班色林 |
1971858-36-2 |
詳細(xì)
|
N-(3,4,5-tribenzyloxybenzyl)quinine chloride |
異噁唑環(huán) |
2138407-51-7 |
詳細(xì)
|
2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate |
瑞德西韋 |
1911578-98-7 |
詳細(xì)
|
BrinzolaMide IMpurity C |
布林佐胺 |
186377-56-0 |
詳細(xì)
|
Bupivacaine IMpurity A |
羅哌卡因 |
205993-83-5 |
詳細(xì)
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
尼達(dá)尼布 |
2037385-84-3 |
詳細(xì)
|
Medetomidine Impurity 51 |
美托咪定 |
2197018-01-0 |
詳細(xì)
|
Aripiprazole-002 |
阿立哌唑 |
2250243-33-3 |
詳細(xì)
|
Remdesivir-001-LR |
瑞德西韋 |
1911578-99-8 |
詳細(xì)
|
S-217622 |
S-217622標(biāo)準(zhǔn)品013 |
1801267-07-1 |
詳細(xì)
|
Balosavir Maposil Impurity 50 |
瑪巴洛沙韋 |
2136287-84-6 |
詳細(xì)
|
2154401-97-3 |
沙羅拉納 |
2154401-97-3 |
詳細(xì)
|
W 36017 |
利多卡因 |
21236-54-4 |
詳細(xì)
|
Bupivacaine Impurity |
布比卡因 |
2125995-28-8 |
詳細(xì)
|
(R)-7-(Benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
瑪巴洛沙韋 |
1985606-53-8 |
詳細(xì)
|
Levofloxacin-006-S |
左氧氟沙星 |
2130840-88-7 |
詳細(xì)
|
S-217622 |
6-氯-1H-吲唑-5-胺 |
221681-75-0 |
詳細(xì)
|
INDEX NAME NOT YET ASSIGNED |
達(dá)格列凈 |
2377899-45-9 |
詳細(xì)
|
Benzoic acid, 4-bromo-3-methyl-, butyl ester |
氟雷拉納 |
1857027-20-3 |
詳細(xì)
|
N-(2,6-dimethylphenyl)nicotinamide |
羅哌卡因 |
1795692-55-5 |
詳細(xì)
|
4-BENZYLOXY-3-METHOXYACETOPHENONE |
多巴胺 |
1835-11-6 |
詳細(xì)
|
synthesis-25 |
|
19319-26-7 |
詳細(xì)
|
ethyl 3-amino-4-methylthiophene-2-carboxylate |
阿替卡因 |
190375-17-8 |
詳細(xì)
|
Tianeptine intermediate |
噻奈普汀 |
1809278-99-6 |
詳細(xì)
|
Dapoxetine impurity |
達(dá)泊西汀 |
2242008-37-1 |
詳細(xì)
|
Methyl 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylate |
瑪巴洛沙韋 |
2136287-59-5 |
詳細(xì)
|
n-1 |
瑞德西韋 |
1884576-18-4 |
詳細(xì)
|
Elagolix-003-R-H2SO4 |
噁拉戈利 |
2375499-59-3 |
詳細(xì)
|
1H-Inden-1-one, 2,3-dihydro-3-hydroxy-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methylene]- |
多奈哌齊 |
2097683-70-8 |
詳細(xì)
|
Butylphthalide impurity |
丁苯酞 |
20871-40-3 |
詳細(xì)
|
Remdesivir Impurity 44 |
瑞德西韋 |
2096990-00-8 |
詳細(xì)
|
Prazosin hydrochloride |
特拉唑嗪 |
19237-84-4 |
詳細(xì)
|
4-Bromopyrazole |
巴瑞克替尼 |
2075-45-8 |
詳細(xì)
|
4-Chloro-3-cyano-7-ethoxy-6-nitroquinoline |
來那替尼 |
214476-09-2 |
詳細(xì)
|
Bupivacaine Impurity |
布比卡因 |
2125995-24-4 |
詳細(xì)
|
Bupivacaine Impurity |
布比卡因 |
2125995-27-7 |
詳細(xì)
|
Methisosildenafil Impurity |
艾地那非 |
1873303-87-7 |
詳細(xì)
|
6-(Chloromethyl)uracil |
替比拉西 |
18592-13-7 |
詳細(xì)
|
HA966 |
4-甲氧基芐氧胺 |
21038-22-2 |
詳細(xì)
|
Acotiamide Impurity |
帕瑞昔布 |
198470-83-6 |
詳細(xì)
|
Bupivacaine Impurity |
布比卡因 |
2125995-26-6 |
詳細(xì)
|
Dapoxetine impurity |
達(dá)泊西汀 |
2242008-36-0 |
詳細(xì)
|
Olanexidine-008-HCl |
奧蘭西丁 |
218282-71-4 |
詳細(xì)
|
LeterMovir-004-salt-EA2 |
萊特莫韋 |
2244994-24-7 |
詳細(xì)
|
AcotiaMide IMpurity 6 Maleate |
阿考替胺 |
185103-81-5 |
詳細(xì)
|
(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate |
瑪巴洛沙韋 |
2136287-68-6 |
詳細(xì)
|
Dapoxetine-004 |
達(dá)泊西汀 |
2245197-07-1 |
詳細(xì)
|
Molnupiravir |
莫匹拉韋 |
2349386-89-4 |
詳細(xì)
|
4-formyl-3-methoxybenzonitrile |
非奈利酮 |
21962-45-8 |
詳細(xì)
|
Benzenebutanenitrile, α-(aminomethylene)-2-fluoro-γ-oxo-, (αE)- |
伏諾拉生 |
2304978-57-0 |
詳細(xì)
|
Articaine-014 |
阿替卡因 |
23964-64-9 |
詳細(xì)
|
Cinchonanium, 1-(9-anthracenylmethyl)-9-hydroxy-6'-methoxy-, chloride, (8α,9R)- |
異噁唑環(huán) |
199588-84-6 |
詳細(xì)
|
3,3'-(ethane-1,2-diyl)bis(1-(2-chloroethyl)-1H-benzo[d]imidazol-2(3H)-one) |
氟班色林 |
191977-79-4 |
詳細(xì)
|
Ropivacaine-ET |
羅哌卡因 |
2180-94-1 |
詳細(xì)
|
Bupivacaine Impurity |
布比卡因雜質(zhì)6 |
2125994-25-2 |
詳細(xì)
|
Levofloxacin-008-S |
左氧氟沙星 |
2130840-92-3 |
詳細(xì)
|
Benzenemethanesulfonic acid, 4-(methylamino)- (ACI) |
奧拉替尼 |
2124221-11-8 |
詳細(xì)
|
S-217622 |
2H-INDAZOLE, 6-CHLORO-2-METHYL-5-NITRO- |
1801267-04-8 |
詳細(xì)
|
Pralidoxime Chloride-003-Cl |
氯解磷定 |
21032-31-5 |
詳細(xì)
|
Articaine-010 |
阿替卡因 |
2169099-30-1 |
詳細(xì)
|
1H-Inden-1-one, 2,3-dihydro-2-(hydroxy-4-piperidinylmethyl)-5,6-dimethoxy- |
多奈哌齊 |
2227606-39-3 |
詳細(xì)
|
Propanedinitrile, 2-[2-(3-fluorophenyl)-2-oxoethyl]- |
伏諾拉生 |
2304978-51-4 |
詳細(xì)
|
4-(methoxycarbonyl)-1-naphthoic acid |
阿福拉納 |
21426-90-4 |
詳細(xì)
|
synthesis-20 |
|
1880973-32-9 |
詳細(xì)
|
Dapagliflozin-022 |
達(dá)格列凈 |
2183515-32-2 |
詳細(xì)
|
3-AMINO-4-METHYL-2-THIOPHENECARBOXYLIC ACID |
阿替卡因 |
23968-18-5 |
詳細(xì)
|
TERT-BUTYL [(1S)-1-(3-METHOXYPHENYL)ETHYL]CARBAMATE |
卡巴列汀 |
218900-56-2 |
詳細(xì)
|
2-ethylbutyl ((R)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate |
瑞德西韋 |
2093124-26-4 |
詳細(xì)
|
Spiro[azetidine-3,1'(3'H)-isobenzofuran], 5'-bromo- |
沙羅拉納 |
2089316-24-3 |
詳細(xì)
|
Ethanone, 1-[3-chloro-4-fluoro-5-(trifluoromethyl)phenyl]-2,2,2-trifluoro- |
阿福拉納 |
2138407-75-5 |
詳細(xì)
|
Levofloxacin-007-S |
左氧氟沙星 |
2130840-90-1 |
詳細(xì)
|
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
帕布昔利布 |
1883672-48-7 |
詳細(xì)
|
2154401-99-5 |
沙羅拉納 |
2154401-99-5 |
詳細(xì)
|
Spiro[azetidine-3,1'(3'H)-isobenzofuran], 5'-[(5S)-5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-, compd. with benzenesulfonate (1:1) |
沙羅拉納 |
2097130-30-6 |
詳細(xì)
|
4,4'-azobis(phenol) |
卡博替尼 |
2050-16-0 |
詳細(xì)
|
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, phosphate (1:1) |
蘆可替尼 |
1911644-31-9 |
詳細(xì)
|
S-217622 |
S-217622標(biāo)準(zhǔn)品014 |
1890002-53-5 |
詳細(xì)
|
LeterMovir-004-salt-EA1 |
萊特莫韋 |
2241754-97-0 |
詳細(xì)
|
3-O-Methylnaltrexone Ethylene Ketal |
納曲酮 |
197242-23-2 |
詳細(xì)
|
synthesis-11 |
2-Propenamide, N-(2-chloro-4-methylphenyl)-3-ethoxy- |
2169776-07-0 |
詳細(xì)
|
synthesis-10 |
6-氨基苯并[1,3]二氧雜環(huán)戊烯-5-甲醛 |
23126-68-3 |
詳細(xì)
|
synthesis-1 |
synthesis-022 |
187170-37-2 |
詳細(xì)
|
Benzenecarbothioamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl- |
阿帕他胺 |
2110425-88-0 |
詳細(xì)
|
S-217622 |
S-217622標(biāo)準(zhǔn)品006 |
1823844-06-9 |
詳細(xì)
|
INDEX NAME NOT YET ASSIGNED |
氟雷拉納 |
2248680-88-6 |
詳細(xì)
|
2-(Hydroxy(pyridin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one |
多奈哌齊 |
2227606-37-1 |
詳細(xì)
|
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-7-(hexyloxy)-3,4,12,12a-tetrahydro-, (12aR)-, compd. with methanesulfonate (1:1) |
瑪巴洛沙韋 |
2136287-70-0 |
詳細(xì)
|
Baricitinib Impurity 9 |
蘆可替尼 |
1911644-33-1 |
詳細(xì)
|
2-Thiophenecarboxylicacid,3-amino-4-methyl-,1-methylethylester(9CI) |
阿替卡因 |
190375-16-7 |
詳細(xì)
|
synthesis-11 |
2-Propenamide, N-(4-chloro-2-methylphenyl)-3-ethoxy- |
2169767-97-7 |
詳細(xì)
|